Analysis: New Safety Rules Unlikely to Trigger Mass Delistings of Chinese Traditional Medicines
1. A new Chinese regulation requires pharmaceutical companies to explicitly list safety risks—such as contraindications, adverse reactions, and precautions—on the...
